Market News How it works Learn FAQ
| GPUS 0.1689 34.05% | XXII 0.1977 -8.34% | SHFS 0.1324 -61.39% | NVD 4.19 0.96% | LUCD 0.411 25.42% | SPCX 147.49 1.89% | T 20.93 -7.96% | SOXL 83.56 1.77% | NU 15.16 2.92% | NOK 8.14 3.30% | EWZ 42.59 1.77% | NVDA 210.96 -0.59% | RIME 0.106 -12.90% | INTC 86.96 1.72% | TSLG 4.87 -1.62% | AAL 12.11 -3.89% | BBD 4.07 3.04% | STLA 4.06 -4.81% | SOXS 52.46 -1.85% | RWM 14.55 0.34% | HYG 77.05 -0.06% | MYND 0.24 47.42% | BITO 10.83 -0.28% | SPDN 8.54 0.47% | YFOR 0.2236 -1.58% | RBNE 0.19 -2.56% | TQQQ 66.29 -0.20% | VZ 44.66 -1.19% | TSLL 9.76 -1.21% | SPTI 27.63 -0.11% | YMAT 2.05 6.77% | CRWV 54.235 -2.46% | INFY 12.35 -6.58% | RIG 6.41 5.43% | F 11.6 -2.85% | SQQQ 39.68 0.20% | AIOK 12.02 182.82% | ONDS 6.2 2.99% | AAPL 347.725 -0.14% | LABT 0.31 -36.67% | CDE 13.45 -3.10% | PCG 12.63 -2.70% | GRAB 2.79 -2.11% | SOFI 14.615 -1.05% | XLE 69.33 2.60% | IREN 24.905 -2.37% | QID 14.55 0.14% | RKT 11.73 -0.09% | WULF 11.32 0.00% | BE 193.3 -11.24%
TETempus AI, Inc. logo

Tempus AI, Inc. (TEM)

NASDAQ · Currency in USD
$67.62 ▲ +3.81 (+5.96%)
At close: Oct 23, 4:00 PM ET. Market closed.
$67.05 ▼ -0.56 (-0.84%)
After hours: Oct 23, 7:58 PM ET

Summary

Previous Close
$63.81
Open
$63.88
Day's Range
$62.67 – $68.13
52 Week Range
$40.77 – $93.38
Volume
4,674,707
Avg. Volume
6,527,190
Market Cap
$11.98B
Beta (5Y Monthly)
3.54
PE Ratio (TTM)
--
EPS (TTM)
-$1.41
Earnings Date
Nov 2, 2026
Forward Dividend & Yield
--
Ex-Dividend Date
--
1y Target Est
$72.60

Profile: Tempus AI, Inc.

Sector
Healthcare
Industry
Medical - Healthcare Information Services
Full-time employees
3,800
CEO
Eric Lefkofsky
Website
tempus.com

Tempus AI, Inc. operates as a healthcare technology company in the United States. It offers the Tempus platform, a closed-loop, full-stack, bi-directional integrations between a clinician's desktop and its laboratory diagnostic capabilities, analytics platform, and repository of multimodal data; and Hub, a clinical application for physicians and other healthcare providers for use in the diagnostics product line as an end-to-end application for healthcare providers for NGS tests. The company also provides Lens, a software application for life sciences and advanced precision research; diagnostics services, such as NGS diagnostics, PCR profiling, and other anatomic and molecular pathology tests; and large-panel solid tumor and hematologic testing through multiple assays, with its core clinical assay (xT and xR) offering large panel DNA, RNA full transcriptome, and incidental germline findings through normal blood or saliva analyses.

Earnings

Next report: Mon, Nov 2, 2026
EPS estimate -$0.08 · Revenue est. $409.39M
DateEst.Actual
Jul 30, 2026-$0.14-$0.04Beat
May 5, 2026-$0.21-$0.13Beat
Feb 24, 2026-$0.04-$0.04Beat
Nov 4, 2025-$0.17-$0.11Beat
Aug 8, 2025-$0.23-$0.22Beat
May 6, 2025-$0.26-$0.24Beat

Analyst view

Consensus price target
$72.60 ▲ +7.4%
Range $50.00 – $92.00
Rating: Buy
Buy 64% · Hold 36% · Sell -0%

Get free alerts on TEM and big market moves

Free special alerts by text & email on new investment opportunities, buyouts and the stocks moving most, in plain English.
Get free stock alerts →
Data: Financial Modeling Prep. For information only, not investment advice.